AcuFocus, Inc.
USPTO PatentsView assignee record - 30 granted patents across 13 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Acufocus ranks #10,238 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 13 technology areas.
- #10,238
- of 49,997 US assignees by volume
- Top 33%
- by Innovation Score (41.3/100)
- 18.0
- avg claims per patent
- -24%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10238 · US Corporation #10,238 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,238/49,997
- PHOTO-FINISH Adaptive Computing…
- CPC-FOCUS A61F · 13 areas
- INNOV-PAR 41.3/100
- CLAIMS-RICH 18.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -24% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Adaptive Computing Enterprises, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Acufocus’s 41.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Acufocus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Abraxis BioScience · near
Abraxis BioScience · near
41 score
- ABT · near
ABT · near
41 score
- AcuFocus · this assignee
AcuFocus · this assignee
41 score
- BOE (Hebei) Mobile… · near
BOE (Hebei) Mobile… · near
41 score
- Sisvel Technology S… · near
Sisvel Technology S… · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Acufocus's Innovation Score is 41.3/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Acufocus?
Each dot is one of Acufocus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acufocus’s own 18.0 claims/patent is ABOVE the 8.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Acufocus's grants concentrate
AcuFocus, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2021. By volume, Acufocus sits between Arlanxeo Singapore PTE. Ltd. and Altium Packaging LP.
Acufocus's three-year grant acceleration
AcuFocus, Inc. shows 8 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at AcuFocus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Arlanxeo Singapor…
Arlanxeo Singapore PTE. Ltd.
30 patents
- Ascentage Pharma…
Ascentage Pharma (SUZHOU) Co., Ltd.
30 patents
- Asus Technology L…
Asus Technology Licensing Inc.
30 patents
- Azurewave
Azurewave Technologies, Inc.
30 patents
- Adaptive Computin…
Adaptive Computing Enterprises, Inc.
30 patents
- Agricultural Rese…
Agricultural Research and Development Limited Liability Company
30 patents
- All-clad Metalcra…
All-Clad Metalcrafters, L.L.C.
30 patents
- Altium Packaging
Altium Packaging LP
30 patents
- Acufocus ◀
AcuFocus, Inc.
30 patents
What this shows AcuFocus holds 30 patents at rank #10,251, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near AcuFocus
By rank, the assignees closest to #10,251 in granted patent volume.
- Arlanxeo Singapore PTE. Ltd. #10,247 · 30 patents
- Ascentage Pharma (SUZHOU) Co., Ltd. #10,248 · 30 patents
- Asus Technology Licensing Inc. #10,249 · 30 patents
- Azurewave Technologies, Inc. #10,250 · 30 patents
- Adaptive Computing Enterprises, Inc. #10,252 · 30 patents
- Agricultural Research and Development Limited Liability Company #10,253 · 30 patents
- All-Clad Metalcrafters, L.L.C. #10,254 · 30 patents
- Altium Packaging LP #10,255 · 30 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in AcuFocus's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for AcuFocus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), AcuFocus ranks #216 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Acufocus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 33% higher than 67% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 10.0% |
| 2016 | 3 | 10.0% |
| 2017 | 5 | 16.7% |
| 2018 | 2 | 6.7% |
| 2019 | 4 | 13.3% |
| 2020 | 4 | 13.3% |
| 2021 | 1 | 3.3% |
| 2022 | 5 | 16.7% |
| 2023 | 2 | 6.7% |
| 2024 | 1 | 3.3% |
Which technologies does AcuFocus, Inc. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
AcuFocus, Inc.'s patent record in context - here's where to go next.
- AcuFocus, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #10,238 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare AcuFocus, Inc. against Arlanxeo Singapore PTE. Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.